News & Updates
Showing Multidisciplinary articles
Showing

RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.

Nontargeted better than targeted screening at identifying HCV cases in EDs
A non–risk-based screening approach for hepatitis C virus (HCV) infection in the emergency department (ED), where all eligible patients were offered rapid testing, improves the identification of new infections when compared with a targeted approach of narrowly focusing on at-risk groups, according to the DETECT Hep C trial.

Ecnoglutide trims weight in adults with obesity
Once-a-week treatment with ecnoglutide demonstrates superiority over placebo, with sustained reductions in body weight and improvements in cardiometabolic indexes among adults with overweight or obesity, reports a study presented at ADA 2025.





